×

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

  • US 10,709,736 B2
  • Filed: 12/04/2019
  • Issued: 07/14/2020
  • Est. Priority Date: 02/21/2018
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence of SEQ ID NO:

  • 6,wherein said cancer is selected from AML (acute myeloid leukemia), BRCA (breast cancer), CCC (cholangiocellular carcinoma), CRC (colorectal cancer), GBM (glioblastoma), GC (gastric cancer), HCC (hepatocellular carcinoma), HNSCC (head and neck squamous cell carcinoma), MEL (melanoma), NHL (non-Hodgkin lymphoma), NSCLC (non-small cell lung cancer), OC (ovarian cancer), OSCAR (esophageal cancer), RCC (renal cell carcinoma), SCLC (small cell lung cancer), UBC (urinary bladder carcinoma), and UEC (uterine endometrial cancer).

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×